Importantly, the proliferation/survival advantage of mutp53-expressing DCIS and 4T1 cells in low AA was abolished by inhibition of either PHGDH, LAT1 or their combination (Fig. 6a, b). The gene discussed is PHGDH; the disease is ductal breast carcinoma in situ.